Back to search results

Robotic Exoskeletons for Stroke Recovery

This study is looking at how different robotic exoskeletons (EksoNR, Atalante X, and ReStore™) compare to standard care in helping people walk better after a stroke. The goal is to find out which device works best for different patients, helping doctors choose the right one for rehabilitation. You may be able to join if you are 50 to 80 years old, had a stroke 3 to 8 months ago, have weakness on one side of your body (unilateral hemiparesis), and meet certain height and weight requirements. We will measure how far and fast you can walk, and how easily you can move around, after 4 weeks of treatment.

Study design
This interventional study plans to enroll 96 participants. It compares three different robotic exoskeletons to standard of care treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The main measurements for walking ability will be taken at 4 weeks after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06736171

Post Stroke Ambulation Recovery Using Robotic Exoskeletons

Recruiting
NAAges 50–80InterventionalTreatment
Kessler Foundation
~96 participants
Updated 2025-09-02 on ClinicalTrials.gov
What's tested:Robotic ExoskeletonSOC

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
10MWT (Aim 1)
Measured over Change from Baseline 10MWT at 4 weeks
+9 more outcomes measured

Conditions

Hemiparesis After Stroke

Explore related trials

Hemiparesis

NCT06736171

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Kessler Foundation

    West Orange, New Jerseystudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Sharon Franco
[email protected]
973-324-3521
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Stroke survivors 3 - 8 months from a recent stroke.
Age: 50 - 80 years
Unilateral hemiparesis
Medical clearance by the Medical Director
Be able to physically fit into the exoskeleton device: Height between 60\" and 76\" and weight below 220 lbs
Patient cognitive status and ability to communicate in English must be at a level consistent with that required to participate in standard motor rehabilitation (e.g. can follow directions).
Adequate cognitive function to give informed consent, understand the training, instructions, use investigational devices and give adequate feedback.
Have a joint range of motion within normal functional limits for ambulation.
Have sufficient strength to use the hemiwalker, cane or walker (etc. assistive device) while wearing the RE.
No history of injury or pathology to the unaffected limb.
Have an appropriate walking speed as determined by the study staff.

Exclusion

Any medical issue that precludes full weight-bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity).
Skin issues that would prevent wearing the device.
Pre-existing condition that caused exercise intolerance (documented uncontrolled hypertension, coronary artery disease, cardiac arrhythmia, or congestive heart failure).
Hospitalization for heart attack, heart surgery, or acute heart failure within 3 months of enrollment in the study.
Uncontrolled seizure disorder, spasticity, or joint contracture that would interfere with walking.
Neuromuscular, neurological, or orthopedic pathologies that interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs.

What this trial measures

  • 10MWT (Aim 1)Change from Baseline 10MWT at 4 weeks

    10 meter walk test to evaluate walking speed after stroke and in response to the intervention.

  • 6MWT (Aim 1)Change from Baseline 6MWT at 4 weeks

    6 minute walking test to evaluate endurance after stroke and in response to the intervention

  • TUG (Aim 1)Change from Baseline TUG at 4 weeks

    Timed up and go (TUG) test to measure functional balance and walking ability after stroke and in response to the intervention.

  • DGI (Aim 1)Change from Baseline DGI at 4 weeks

    Dynamic Gait Index (DGI) evaluates the ability to modify balance while walking in the presence of external demands after stroke and in response to the intervention.

  • Berg Balance Scale (Aim 1)Change from Baseline Berg at 4 weeks

    Measure to assess static and dynamic balance and fall risk after stroke and in response to the intervention.

  • Joint Range of Motion (kinematics) (Aim 2)Change from Baseline at 4 weeks

    Kinematics gait data will be collected using a motion capture camera system to provide biomechanical outcomes.

  • Temporospatial Loading (Aim 2)Change from Baseline at 4 weeks

    Step length, timing during gait cycle, limb symmetry will be collected using instrumented gait walkway and insoles.

  • Balance (Aim 2)Change from Baseline at 4 weeks

    Static and dynamic balance in standing and seated positions after stroke and in response to the intervention (using Hunova (Movendo Inc, Genova, Italy) plaform).

  • Survey for Community Participation (Aim 3)Change from Baseline at 4 weeks

    The Community Participation Indicators (CPI) is a self-reported 48 item objective measure survey.

  • Survey for Quality of Life (Aim 3)Change from Baseline at 4 weeks

    The SS-QOL survey assesses health-related quality of life (QOL) specific to stroke survivors with 49 items across 12 domains.